SFX by Ex Libris Inc.

Title:	A chikungunya fever vaccine utilizing an insect-specific virus platform
Source:	Nature Medicine [1078-8956] Erasmus, Jesse yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ramsauer, K. "Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial." Lancet (British edition) 392.10165 (2018): 2718-2727.
description	2.	Smalley, C. "Status of research and development of vaccines for chikungunya." Vaccine 34.26 (2016): 2976-2981.
description	3.	Tretyakova, I. "DNA Vaccine Initiates Replication of Live Attenuated Chikungunya Virus In Vitro and Elicits Protective Immune Response in Mice." The Journal of infectious diseases 209.12 (2014): 1882-1890.
description	4.	Yano, Y. "Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life." JAMA : the journal of the American Medical Association 320.17 (2018): 1774-1782.
description	5.	Grobusch, Martin P. "Long-term sequelae of chikungunya virus disease: A systematic review." Travel medicine and infectious disease 15.C: 8-22.
description	6.	"Chikungunya: A rheumatologist's perspective." International journal of rheumatic diseases 21.3: 584-601.
description	7.	Casal, Pablo E. "Evidence for homologous recombination in Chikungunya Virus." Molecular phylogenetics and evolution 85 (2015): 68-75.
description	8.	Olowokure, B. "The Caribbean response to chikungunya." The Lancet infectious diseases 14.11 (2014): 1039-40.
description	9.	Pangankar, Mandar S. "Identification of chikungunya virus interacting proteins in mammalian cells." Journal of Biosciences 39.3 (2014): 389-399.
description	10.	Bettadapura, J. "Approaches to the treatment of disease induced by chikungunya virus." Indian Journal of Medical Research 138.5 (2013): 762-765.
description	11.	Mahalingam, Mark J. "Chikungunya: a re-emerging virus." Lancet 379.9816 (2011): 662-671.
description	12.	Zuniga, A. "Attenuated measles virus as a vaccine vector." Vaccine 25.16 (2007): 2974-83.
description	13.	Desenclos, J-C C. "Transmission parameters of vector-borne infections." Médecine et maladies infectieuses 41.11 (2011): 588-593.
description	14.	Sheppard, James P. "Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension." JAMA internal medicine. 178.12: 1626-1634.
description	15.	Burt, Felicity J. "Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen." The Lancet infectious diseases 17.4 (2017): 107-117.
description	16.	Benzekri, R. "Third Cranial Nerve Palsy in the Setting of Chikungunya Virus Infection." The American journal of tropical medicine and hygiene 95.1 (2016): 180-181.
description	17.	Gérardin, P. "Neurocognitive Outcome of Children Exposed to Perinatal Mother-to-Child Chikungunya Virus Infection: The CHIMERE Cohort Study on Reunion Island (Neurocognitive Outcome of Neonatal Chikungunya)." PLoS Neglected Tropical Diseases 8.7 (2014).
description	18.	Evenson, Kelly R. "Prevalence of Physical Activity and Sedentary Behavior Among Adults With Cardiovascular Disease in the United States." Journal of cardiopulmonary rehabilitation and prevention Publish Ahead of Print.6 (2014): 1-19.
description	19.	James, Gary D. "Ambulatory blood pressure and blood lipids in a multiethnic sample of healthy adults." American journal of human biology 25.4 (2013): 563-565.
description	20.	Johnson, Heather M. "Antihypertensive Medication Initiation Among Young Adults with Regular Primary Care Use." Journal of general internal medicine 29.5 (2014): 723-731.